ImageneBio (IMA) Cash from Investing Activities (2020 - 2025)

ImageneBio has reported Cash from Investing Activities for 6 years, with the latest figure at -$37.3 million in Q3 2025.

• Quarterly Cash from Investing Activities fell 166.85% year-over-year to -$37.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$50.4 million (down 260.44% YoY) and the FY2024 annual result came in at -$34.9 million, down 154.41% from the prior year.
• Cash from Investing Activities fell to -$37.3 million in Q3 2025 per IMA's latest filing, from $32.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $55.8 million in Q3 2024 and troughed at -$166.1 million in Q1 2022.
• A 5-year average of -$4.2 million and a median of $1.9 million in 2021 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 19546.74% in 2022, down 19691.54% in 2022.
• Over 5 years, Cash from Investing Activities stood at -$550000.0 in 2021, then soared by 2008.91% to $10.5 million in 2022, then jumped by 94.08% to $20.4 million in 2023, then slumped by 325.38% to -$45.9 million in 2024, then climbed by 18.71% to -$37.3 million in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$37.3 million, $32.9 million, and -$45.9 million for Q3 2025, Q2 2025, and Q4 2024 respectively.